Follow
Dr. Sreekanth Thota
Dr. Sreekanth Thota
Professor (Pharmaceutical Chemistry & Medicinal Chemistry)
Verified email at cdts.fiocruz.br - Homepage
Title
Cited by
Cited by
Year
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
S Thota, DA Rodrigues, DC Crans, EJ Barreiro
Journal of Medicinal Chemistry 61 (14), 5805-5821, 2018
4062018
N-Acylhydrazones as drugs
S Thota, DA Rodrigues, PSM Pinheiro, LM Lima, CAM Fraga, EJ Barreiro
Bioorganic & Medicinal Chemistry Letters 28 (17), 2797-2806, 2018
1702018
Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds
SS Karki, S Thota, SY Darj, J Balzarini, E De Clercq
Bioorganic & Medicinal Chemistry 15 (21), 6632-6641, 2007
912007
Metal Nanoparticles: Synthesis and Applications in Pharmaceutical Sciences
S Thota, DC Crans
John Wiley & Sons, 2018
822018
EDITORIAL (thematic issue: treatment and diagnosis of diabetes mellitus and its complication: advanced approaches)
S Sen, R Chakraborty
Mini reviews in medicinal chemistry 15 (14), 1132-1133, 2015
592015
Synthesis of thiocarbohydrazide and carbohydrazide derivatives as possible biologically active agents
K Gangarapu, S Manda, A Jallapally, S Thota, SS Karki, J Balzarini, ...
Medicinal Chemistry Research 23, 1046-1056, 2014
432014
Synthesis, characterization, DNA binding, DNA cleavage, protein binding and cytotoxic activities of Ru (II) complexes
S Thota, S Vallala, R Yerra, DA Rodrigues, NM Raghavendra, EJ Barreiro
International Journal of Biological Macromolecules 82, 663-670, 2016
422016
Design, Synthesis and Pharmacological Evaluation of First‐in‐Class Multitarget N‐Acylhydrazone Derivatives as Selective HDAC6/8 and PI3Kα Inhibitors
DARFSGFSSP de Sena M. Pinheiro Marina A. Alves Sreekanth Thota Lorrane S ...
ChemMedChem, 2020
362020
The use of conformational restriction in medicinal chemistry
P de Sena M Pinheiro, DA Rodrigues, R do Couto Maia, S Thota, ...
Current topics in medicinal chemistry 19 (19), 1712-1733, 2019
312019
Design, synthesis, characterization, antioxidant and in vitro cytotoxic activities of novel coumarin thiazole derivatives
S Thota, K Nadipelly, A Shenkesi, R Yerra
Medicinal Chemistry Research 24, 1162-1169, 2015
272015
Novel mononuclear ruthenium (II) compounds in cancer therapy
SS Anchuri, S Thota, R Yerra, KP Devarakonda, S Dhulipala
Asian Pacific Journal of Cancer Prevention 13 (7), 3293-3298, 2012
252012
Microwave assisted synthesis, characterization of some new isatin and thiophene derivatives as cytotoxic and chemopreventive agents
K Gangarapu, S Manda, S Thota, R Yerra, S S Karki, J Balzarini, ...
Letters in Drug Design & Discovery 9 (10), 934-941, 2012
242012
Synthesis, spectroscopic characterization, antineoplastic, in vitro-cytotoxic, and antibacterial activities of mononuclear ruthenium (II) complexes
S Thota, M Imran, M Udugula, SS Karki, N Kanjarla, R Yerra, J Balzarini, ...
Journal of Coordination Chemistry 65 (5), 823-839, 2012
232012
Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes
S Thota, SS Karki, KN Jayaveera, J Balzarini, ED Clercq
Journal of Enzyme Inhibition and Medicinal Chemistry 25 (4), 513-519, 2010
232010
Methods for preparation of metal nanoparticles
S Iravani, S Thota, DC Crans
Metal nanoparticles: synthesis and applications in pharmaceutical sciences …, 2017
212017
Beyond the selective inhibition of histone deacetylase 6
D A Rodrigues, S Thota, C AM Fraga
Mini Reviews in Medicinal Chemistry 16 (14), 1175-1184, 2016
182016
Design, synthesis, characterization, cytotoxic and structure activity relationships of novel Ru (II) complexes
S Thota, S Vallala, R Yerra, EJ Barreiro
Chinese Chemical Letters 26 (6), 721-726, 2015
182015
Synthesis, spectroscopic characterization, in vitro cytotoxic and structure activity relationships of some mononuclear Ru (II) complexes
S Thota, S Vallala, M Imran, S Mekala, SS Anchuri, SS Karki, R Yerra, ...
Journal of Coordination Chemistry 66 (6), 1031-1045, 2013
172013
Drug Discovery and Development of Antimalarial Agents: Recent Advances.
S Thota, R Yerra
Current Protein & Peptide Science 17 (3), 275-279, 2016
162016
Structural basis for the agonist action at free)
DA Rodrigues, PSM Pinheiro, TTSC Ferreira, S Thota, CAM Fraga
Chemical Biology & Drug Design 91 (3), 668-680, 2018
152018
The system can't perform the operation now. Try again later.
Articles 1–20